Parkinson's Disease and the Microbiota-Gut-Brain Axis: Metabolites, Mechanisms, and Innovative Therapeutic Strategies Targeting the Gut Microbiota
Molecular Neurobiology · 2025-04 · 62 (4) · 5273-5296
DOI: 10.1007/s12035-024-04584-9 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Molecular Neurobiology, online erschienen am 12.11.2024. Verfasst von Zhao Ran und 5 weiteren Autor:innen. Beteiligte Einrichtung: Chongqing Key Laboratory of Sichuan-Chongqing Co-Construction for Diagnosis and Treatment of Infectious Diseases Integrated Traditional Chinese and W…. Hauptthemen laut MEDLINE: Parkinson Disease, Gastrointestinal Microbiome, Brain, Brain-Gut Axis. Die Arbeit wurde bisher 21-mal zitiert (Crossref) und nennt 187 Literaturangaben. Gefördert von: Joint Innovation Fund Project of Chengdu University of TCM and Affiliated Hospitals, Sichuan Provincial Science and Technology Support Program.
Abstract (Originalsprache)
The human gut microbiota is diverse and abundant and plays important roles in regulating health by participating in metabolism and controlling physiological activities. The gut microbiota and its metabolites have been shown to affect the functioning of the gut and central nervous system through the microbiota-gut-brain axis. It is well established that microbiota play significant roles in the pathogenesis and progression of Parkinson's disease (PD). Disorders of the intestinal microbiota and altered metabolite levels are closely associated with PD. Here, the changes in intestinal microbiota and effects of metabolites in patients with PD are reviewed. Potential mechanisms underlying intestinal microbiota disorders in the pathogenesis of PD are briefly discussed. Additionally, we outline the current strategies for the treatment of PD that target the gut microbiota, emphasizing the development of promising novel strategies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Chongqing Key Laboratory of Sichuan-Chongqing Co-Construction for Diagnosis and Treatment of Infectious Diseases Integrated Traditional Chinese and Western Medicine, College of Medical Technology, Chengdu University of…
- College of Basic Medical Sciences, Chengdu University of Traditional Chinese Medicine, Chengdu, 611137, China.
- Jiangsu Key Laboratory of Neuropsychiatric Diseases, Institute of Neuroscience, Soochow University, Suzhou, 215021, China.
- Jiangsu Key Laboratory of Neuropsychiatric Diseases, Institute of Neuroscience, Soochow University, Suzhou, 215021, China. maquanhong@suda.edu.cn.
Förderung
- Joint Innovation Fund Project of Chengdu University of TCM and Affiliated Hospitals
- Sichuan Provincial Science and Technology Support Program
Zitieren
APA
Ran, Z., Mu, B. R., Wang, D. M., Xin-Huang, Ma, Q. H., & Lu, M. H. (2025). Parkinson's Disease and the Microbiota-Gut-Brain Axis: Metabolites, Mechanisms, and Innovative Therapeutic Strategies Targeting the Gut Microbiota. Molecular Neurobiology, 62(4), 5273-5296. https://doi.org/10.1007/s12035-024-04584-9
Vancouver
Ran Z, Mu BR, Wang DM, Xin-Huang, Ma QH, Lu MH. Parkinson's Disease and the Microbiota-Gut-Brain Axis: Metabolites, Mechanisms, and Innovative Therapeutic Strategies Targeting the Gut Microbiota. Molecular Neurobiology. 2025;62(4):5273-5296. doi:10.1007/s12035-024-04584-9
BibTeX
@article{Ran2025,
author = {Ran, Zhao and Mu, Ben-Rong and Wang, Dong-Mei and Xin-Huang and Ma, Quan-Hong and Lu, Mei-Hong},
title = {Parkinson's Disease and the Microbiota-Gut-Brain Axis: Metabolites, Mechanisms, and Innovative Therapeutic Strategies Targeting the Gut Microbiota},
journal = {Molecular Neurobiology},
year = {2025},
volume = {62},
number = {4},
pages = {5273--5296},
doi = {10.1007/s12035-024-04584-9}
}
EUVIMED